Evidence map›Paper›PMID 37172498›Full record

ArticleBreast (Edinburgh, Scotland)2023

Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109].

Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, Richard Aziza, Eva Jouve, Slimane Zerdoud, Eleonora De Maio, Carole Massabeau, Maxime Loo, Vincent Esteyrie and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast (Edinburgh, Scotland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Gauthier GlemarecDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Jean-Louis LacazeDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Bastien CabarrouBiostatistics Unit, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Richard AzizaDepartment of Radiology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Eva JouveDepartment of Surgery, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Slimane ZerdoudDepartment of Radiology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Eleonora De MaioDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Carole MassabeauDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Maxime LooDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Vincent EsteyrieDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Mony UngDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Florence DalencDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Francoise IzarDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
Ciprian ChiraDepartment of Radiation Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: chira.ciprian@iuct-oncopole.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37172498
PMCPMC10300574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.